Durable Suppression of Acquired MEK Inhibitor Resistance in Cancer by Sequestering MEK From ERK and Promoting Anti-Tumor T-Cell Immunity
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Durable Suppression of Acquired MEK Inhibitor Resistance in Cancer by Sequestering MEK From ERK and Promoting Anti-Tumor T-Cell Immunity
Cancer Discov 2020 Dec 14;[EPub Ahead of Print], A Hong, M Piva, S Liu, W Hugo, SH Lomeli, V Zoete, CE Randolph, Z Yang, Y Wang, JJ Lee, SJ Lo, L Sun, A Vega-Crespo, AJ Garcia, DB Shackelford, SM Dubinett, PO Scumpia, SD Byrum, AJ Tackett, TR Donahue, O Michielin, SL Holmen, A Ribas, G Moriceau, RS LoFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.